NCT03164395

Brief Summary

This study seeks to determine the efficacy of single coil defibrillation leads for cardioversion of persistent atrial fibrillation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for not_applicable atrial-fibrillation

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 23, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2018

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

1.3 years

First QC Date

May 21, 2017

Last Update Submit

March 20, 2019

Conditions

Keywords

atrial fibrillationimplantable cardiac defibrillatorcardioversion

Outcome Measures

Primary Outcomes (1)

  • Acute Conversion of Atrial Fibrillation to Sinus Rhythm

    Does the patient return for at least one beat to sinus rhythm following the administration of a shock

    Immediate

Study Arms (2)

Internal Cardioversion

EXPERIMENTAL

Patients randomized to external cardioversion will undergo external synchronized cardioversion per institutional protocol.

Procedure: Internal Cardioversion

External Cardioversion

ACTIVE COMPARATOR

Patients randomized to internal cardioversion will have a maximum energy shock delivered from the device between the RV coil and can. If cardioversion is not successful they will then undergo external cardioversion per institutional protocol.

Procedure: External Cardioversion

Interventions

Internal Cardioversion with device maximum output shock from RV coil to Can versus external cardioversion per institutional protocol

Internal Cardioversion

External Cardioversion per institutional protocol

External Cardioversion

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • greater than 18 years of age
  • persistent atrial fibrillation and have been recommended by your primary cardiologist to undergo cardioversion
  • have an implantable cardiac defibrillator

You may not qualify if:

  • over the age of 99
  • pregnant
  • prisoner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Samy C Elayi, MD

    University of Kentucky

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in block fashion to either internal or external cardioversion
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 21, 2017

First Posted

May 23, 2017

Study Start

July 1, 2017

Primary Completion

October 23, 2018

Study Completion

October 23, 2018

Last Updated

March 22, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations